Fasting plasma glucose and HbA1c in cardiovascular risk prediction: a sex-specific comparison in individuals without diabetes mellitus

Hemoglobin A1cTesting Alone Does Not Sufficiently Identify Patients With Prediabetes: Table 1

(2011) Sophie Bersoux et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Impact of Diabetes on Cardiovascular Disease Risk and All-Cause Mortality in Older Men

(2011) S. Goya Wannamethee et al.   ARCHIVES OF INTERNAL MEDICINE

Are the Same Clinical Risk Factors Relevant for Incident Diabetes Defined by Treatment, Fasting Plasma Glucose, and HbA1c?

(2011) B. Balkau et al.   DIABETES CARE

Diagnosis and Classification of Diabetes Mellitus

(2011)   DIABETES CARE

HbA1c and cardiovascular risk score identify people who may benefit from preventive interventions: a 7 year follow-up of a high-risk screening programme for diabetes in primary care (ADDITION), Denmark

(2011) T. Lauritzen et al.   DIABETOLOGIA

Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes and implications for screening

(2011) Ben Schöttker et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Impact of A1C Screening Criterion on the Diagnosis of Pre-Diabetes Among U.S. Adults

(2010) D. M. Mann et al.   DIABETES CARE

A1C Between 5.7 and 6.4% as a Marker for Identifying Pre-Diabetes, Insulin Sensitivity and Secretion, and Cardiovascular Risk Factors: The Insulin Resistance Atherosclerosis Study (IRAS)

(2010) C. Lorenzo et al.   DIABETES CARE

Postchallenge Glucose, A1C, and Fasting Glucose as Predictors of Type 2 Diabetes and Cardiovascular Disease: A 10-year prospective cohort study

(2010) H. Cederberg et al.   DIABETES CARE

Do the Joint British Society (JBS2) guidelines on prevention of cardiovascular disease with respect to plasma glucose improve risk stratification in the general population? Prospective cohort study

(2010) E. J. Brunner et al.   DIABETIC MEDICINE

Methods for evaluating novel biomarkers - a new paradigm

(2010) N. R. Cook   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Pre-Diabetes and the Risk for Cardiovascular Disease

(2010) Earl S. Ford et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

(2010) The Emerging Risk Factors Collaboration   LANCET

Glycated Hemoglobin, Diabetes, and Cardiovascular Risk in Nondiabetic Adults

(2010) Elizabeth Selvin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Markers of Dysglycaemia and Risk of Coronary Heart Disease in People without Diabetes: Reykjavik Prospective Study and Systematic Review

(2010) Nadeem Sarwar et al.   PLOS MEDICINE

Utility of C-Reactive Protein for Cardiovascular Risk Stratification Across Three Age Groups in Subjects Without Existing Cardiovascular Diseases

(2009) Mark Hamer et al.   AMERICAN JOURNAL OF CARDIOLOGY

Standards of Medical Care in Diabetes--2010

(2009)   DIABETES CARE

How much does HDL cholesterol add to risk estimation? A report from the SCORE investigators

(2009) Marie Therese Cooney et al.   EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION

Evaluation of the Framingham Risk Score in the European Prospective Investigation of Cancer–Norfolk CohortDoes Adding Glycated Hemoglobin Improve the Prediction of Coronary Heart Disease Events?

(2008) Rebecca K. Simmons   ARCHIVES OF INTERNAL MEDICINE

The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study

(2008) Guangwei Li et al.   LANCET